12:00 AM
Aug 13, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Trichuris suis ova update

Coronado said the New York University School of Medicine began the double-blind, placebo-controlled, crossover, U.S. MUCUS trial to evaluate CNDO-201 in 18 patients with active UC. The university is investigating the immune response to CNDO-201 in the gastrointestinal tract of UC patients. CNDO-201 is...

Read the full 210 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >